Updated:
Ximedica
Ximedica is a medtech design and development consultancy in Providence, RI, led by CEO Kevin Grim, serving clients from concept through manufacturing.
Ximedica
Ximedica is a medical product and device development firm based in Providence, Rhode Island, established in 1985.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Providence
Corporate office
Providence, RI, United States
Additional offices
Boston, MA, United States
Principals
Kevin Grim
President and CEO
James G. Tague
Chief Operating Officer
David V. Milne
Chief Financial Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Ximedica?
Ximedica is a product development firm, not an investment vehicle. Decisions are made by CEO Kevin Grim and executive leadership. The firm is not known to deploy capital externally.
What types of medical devices does Ximedica work on?
Ximedica covers cardiovascular, orthopedics, surgical instruments, and diagnostic devices. The firm works across the full product lifecycle from ideation to manufacturing.
Is Ximedica a family office, an asset manager, or a service firm?
Ximedica is an engineering and design consultancy. It has no disclosed AUM or investment mandate. Its private equity ownership historically came from Prospect Partners.
Does Ximedica have any disclosed portfolio companies or direct investments?
No. Ximedica does not publicize client names or portfolio holdings. It operates on a fee-for-service model, not an investment basis.
Where is Ximedica's primary geographic focus?
Ximedica serves clients primarily in North America and Western Europe. It has offices in Providence, RI, and Boston, MA.
How does Ximedica handle regulatory affairs for clients?
The firm provides regulatory strategy and submission support for FDA (US), CE marking (Europe), and other international standards. This is integrated into client projects.
What is Ximedica's known posture on co-investments alongside external GPs?
Ximedica does not engage in co-investments. It is a service provider, not a capital partner.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: